Skip to main content

Organizational Readiness for an FDA Audit of a 503B Compounding Pharmacy

Organizational Readiness for an

Listen to Lisa McChesney-Harris, PhD, CEO, CSO and Founder of Prompt Praxis Laboratories, discuss how to apply strategies for achieving an audit-ready organization, maintaining vigilant management oversight in this bioMérieux-sponsored webinar, Organizational Readiness for an FDA Audit of a 503B Compounding Pharmacy, with the American Pharmaceutical Review.

You’ll have the opportunity to learn:

  • strategies for achieving an audit-ready organization
  • how to stay current on enforcement activity
  • how to maintain vigilant management oversight
Watch Now →

Please note this webinar previously aired on May 4, 2023 with the American Pharmaceutical Review.